ADHD in the News 2026-02-26
Boston Legacy FC Announces Sensory Room Sponsorship with Collegium Pharmaceutical
BOSTON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Boston Legacy FC today announced a multi-year partnership with Collegium Pharmaceutical, an emerging biopharmaceutical leader in the Boston area, naming the company an Official Partner of Boston Legacy FC. Through this collaboration, Boston Legacy FC and Collegium are working together to ensure that the club’s home games are welcoming and sensory-inclusive for all fans.
The Boom in ADHD Coaching Has Few Rules
Once a niche offering, attention-deficit/hyperactivity disorder (ADHD) coaching has surged in popularity over the past 5 years, emerging as a common add-on to more traditional care for the condition.
Lineage “Dance for Joy” Program Expands to Serve Youth With ADHD
Beginning March 5, Lineage Performing Arts Center will launch an eight-week Dance for Joy session for youth diagnosed with ADHD.
Black Folks With ADHD May Possess Superpowers, But There’s So Much Else You Should Know
ADHD has two signature super power characteristics: Pattern recognition and “hyperfocus,” both can benefit Black people navigating in this racist world. But wait, there’s another side to having ADHD.
The rise of rejection sensitive dysphoria: ‘My chest feels like it’s collapsing’
It makes rejection, teasing or criticism feel unbearable, often prompting a strong physical reaction. Sufferers describe life with a condition that is only just starting to be understood
Why Are So Many Women Getting ADHD Diagnoses in Midlife?
They’re spotlighting the disorder’s hormonal link — and possibly changing how it’s treated.
Veterans With Homelessness Less Likely to Receive ADHD Stimulant Therapy
Key point: Compared with veterans who are independently housed, those with homelessness are 20% less likely to receive ADHD stimulant medications.
The Hidden Physical Health Risks and Symptoms of Adult ADHD
Key Facts: Adults with ADHD face statistically higher risks for cardiovascular diseases, including hypertension and arterial disorders. Impulsivity serves as a behavioral gateway to health risks like substance misuse, binge eating, and physical inactivity. Preterm birth is a significant predictor of ADHD severity due to disruptions in early fetal brain glucose metabolism and blood flow. Stimulant medications improve health outcomes by reducing risky behaviors, despite potential side effects like elevated heart rate. Early intervention in childhood is a primary preventive measure against the cascade of long-term adult health complications.
Why the ADHD brain is a perfect pairing for AI
Those with the condition tend to struggle in the domains where AI excels, and vice versa.
New ADHD Research Challenges Former Assumptions. Why It Matters
Roughly 11% of all U.S. children ages 3–17 have been diagnosed with ADHD, or attention-deficit/hyperactivity disorder. That’s the equivalent of two to three students in a typical classroom. And the brain-based disorder is only becoming more common. Between 2016 and 2022, about 1 million additional children were diagnosed with ADHD, according to the Centers for Disease Control and Prevention.
Rebecca Chasnovitz, MD, highlights updates in pediatric ADHD medication
New research highlights the fluctuating course of pediatric ADHD and the continued role of stimulant medications as first-line therapy.
What Is Aniracetam?
Key Takeaways: Aniracetam is a supplement that may help improve memory and mood but needs more research for safety and effectiveness. Side effects of aniracetam can include anxiety, irritability, and sleeping problems. Aniracetam may interact with medications for ADHD, allergies, mental health, and blood pressure; consult a healthcare provider before use.
How to Get Out of Your Head
Key points: Some neurodivergent folks get stuck in their heads because of cognitive distortions common brain processes. An important first step is to become aware of these distortions and processes. Awareness can be promoted through practicing effective metacognition in the way that works for you.